These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1484610)

  • 1. Does damage of perivascular astrocytes in multiple sclerosis plaques participate in blood-brain barrier permeability?
    Rafałowska J; Krajewski S; Dolińska E; Dziewulska D
    Neuropatol Pol; 1992; 30(1):73-80. PubMed ID: 1484610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis.
    Misu T; Fujihara K; Kakita A; Konno H; Nakamura M; Watanabe S; Takahashi T; Nakashima I; Takahashi H; Itoyama Y
    Brain; 2007 May; 130(Pt 5):1224-34. PubMed ID: 17405762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathological findings in rats with experimental allergic encephalomyelitis.
    Dong M; Liu R; Guo L; Li C; Tan G
    APMIS; 2008 Nov; 116(11):972-84. PubMed ID: 19132994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple sclerosis. Interactions between oligodendrocytes and hypertrophic astrocytes and their occurrence in other, nondemyelinating conditions.
    Wu E; Raine CS
    Lab Invest; 1992 Jul; 67(1):88-99. PubMed ID: 1625450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid precursor protein (APP) expression in multiple sclerosis lesions.
    Gehrmann J; Banati RB; Cuzner ML; Kreutzberg GW; Newcombe J
    Glia; 1995 Oct; 15(2):141-51. PubMed ID: 8567065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Gliotoxic factor and multiple sclerosis].
    Rieger F; Amouri R; Benjelloun N; Cifuentes-Diaz C; Lyon-Caen O; Hantaz-Ambroise D; Dobransky T; Perron H; Gemy C
    C R Acad Sci III; 1996 Apr; 319(4):343-50. PubMed ID: 8762982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased citrullinated glial fibrillary acidic protein in secondary progressive multiple sclerosis.
    Nicholas AP; Sambandam T; Echols JD; Tourtellotte WW
    J Comp Neurol; 2004 May; 473(1):128-36. PubMed ID: 15067723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The blood-brain barrier (BBB) permeability in multiple sclerosis.
    Rafałowska J; Krajewski S; Dolińska E
    Neuropatol Pol; 1990; 28(1-2):41-54. PubMed ID: 2097537
    [No Abstract]   [Full Text] [Related]  

  • 9. Case report: DNA fragmentation in glial cells in a cerebral biopsy from a multiple sclerosis patient.
    Benjelloun N; Ménard A; Charriaut-Marlangue C; Mokhtari K; Perron H; Hauw JJ; Rieger F
    Cell Mol Biol (Noisy-le-grand); 1998 Jun; 44(4):579-83. PubMed ID: 9678892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The astrocyte in multiple sclerosis revisited.
    Brosnan CF; Raine CS
    Glia; 2013 Apr; 61(4):453-65. PubMed ID: 23322421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The blood-brain barrier in cortical multiple sclerosis lesions.
    van Horssen J; Brink BP; de Vries HE; van der Valk P; Bø L
    J Neuropathol Exp Neurol; 2007 Apr; 66(4):321-8. PubMed ID: 17413323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood-brain barrier changes in multiple sclerosis.
    Trojano M; Manzari C; Livrea P
    Ital J Neurol Sci; 1992 Dec; 13(9 Suppl 14):55-64. PubMed ID: 1345741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced expression of aquaporin 4 in human brain with inflammatory diseases.
    Aoki-Yoshino K; Uchihara T; Duyckaerts C; Nakamura A; Hauw JJ; Wakayama Y
    Acta Neuropathol; 2005 Sep; 110(3):281-8. PubMed ID: 16133546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced number and activity of mitochondria in multiple sclerosis lesions.
    Witte ME; Bø L; Rodenburg RJ; Belien JA; Musters R; Hazes T; Wintjes LT; Smeitink JA; Geurts JJ; De Vries HE; van der Valk P; van Horssen J
    J Pathol; 2009 Oct; 219(2):193-204. PubMed ID: 19591199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Astrocyte Depletion upon Inflammation and Demyelination in a Murine Animal Model of Multiple Sclerosis.
    Allnoch L; Baumgärtner W; Hansmann F
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31409036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased 14-3-3 immunoreactivity in glial elements in patients with multiple sclerosis.
    Kawamoto Y; Akiguchi I; Kovács GG; Flicker H; Budka H
    Acta Neuropathol; 2004 Feb; 107(2):137-43. PubMed ID: 14605832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vimentin-positive astrocytes in canine distemper: a target for canine distemper virus especially in chronic demyelinating lesions?
    Seehusen F; Orlando EA; Wewetzer K; Baumgärtner W
    Acta Neuropathol; 2007 Dec; 114(6):597-608. PubMed ID: 17965866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered glutamate reuptake in relapsing-remitting and secondary progressive multiple sclerosis cortex: correlation with microglia infiltration, demyelination, and neuronal and synaptic damage.
    Vercellino M; Merola A; Piacentino C; Votta B; Capello E; Mancardi GL; Mutani R; Giordana MT; Cavalla P
    J Neuropathol Exp Neurol; 2007 Aug; 66(8):732-9. PubMed ID: 17882017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel astrocytic protein in multiple sclerosis plaques.
    Malhotra SK; Predy R; Johnson ES; Singh R; Leeuw K
    J Neurosci Res; 1989 Jan; 22(1):36-49. PubMed ID: 2926840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired induction of blood-brain barrier properties in aortic endothelial cells by astrocytes from GFAP-deficient mice.
    Pekny M; Stanness KA; Eliasson C; Betsholtz C; Janigro D
    Glia; 1998 Apr; 22(4):390-400. PubMed ID: 9517571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.